Relationship Between Duration of Targeted Temperature Management, Ischemic Interval, and Good Functional Outcome From...

Area of Science:

• Cardiology
• Emergency Medicine
• Critical Care Medicine

Background:

• Targeted temperature management (TTM) is crucial for out-of-hospital cardiac arrest (OHCA) survivors.
• Optimizing TTM duration based on ischemia duration may enhance patient outcomes.
• The hypothermia/ischemia ratio's impact on functional recovery requires further investigation.

Purpose of the Study:

• To investigate the association between the hypothermia/ischemia ratio and functional outcomes in OHCA survivors.
• To determine if tailoring hypothermia duration to ischemia duration improves neurological recovery.
• To analyze data from the Resuscitation Outcomes Consortium (ROC) Amiodarone, Lidocaine, or Placebo Study trial.

Main Methods:

• Secondary analysis of a multicenter cohort study involving adult OHCA patients.
• Patients received TTM between May 2012 and October 2015.
• The hypothermia/ischemia ratio was calculated as TTM duration divided by estimated ischemia time.

Main Results:

• 3,429 patients were eligible; 36.2% achieved good functional outcome (modified Rankin Score 0-3).
• A greater hypothermia/ischemia ratio was associated with increased survival with good functional outcome (OR, 2.01; 95% CI, 1.82-2.23) after adjustment.
• This association was primarily driven by the time to return of spontaneous circulation (ROSC).

Conclusions:

• While a higher hypothermia/ischemia ratio showed association with better outcomes, time to ROSC was the main driver.
• Further prospective studies are needed to tailor TTM duration based on ischemia time or patient characteristics.
• The findings suggest a complex interplay between ischemia, hypothermia, and neurological recovery in OHCA survivors.